| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Jim Wassil53 | Chief Operating Officer | Sell10b5-1 | 7,395 | $58.88 | $435,439.81 | -4.2% | -20.4% | - | |
| Dec 31, 2025 | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Sell | 9,743 | $46.69 | $454,890.93 | -28.9% | +25.9% | - | |
| Dec 23, 2025 | Elvia Cowan71 | SVP, Finance | Sell | 11,623 | $47.92 | $556,971.85 | -44.4% | +17.0% | - | |
| Mar 5, 2025 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $70.74 | $353,699.01 | -10.7% | -53.1% | -21.3% | |
| Mar 3, 2025 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $73.27 | $586,165.11 | -4.9% | -51.4% | -17.0% | |
| Feb 18, 2025 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $83.85 | $670,822.74 | -6.8% | -61.2% | -31.9% | |
| Feb 5, 2025 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $90.07 | $450,368.64 | -15.1% | -67.3% | -39.7% | |
| Feb 3, 2025 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $86.22 | $689,790.43 | -3.7% | -59.6% | -34.3% | |
| Jan 21, 2025 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $86.51 | $692,100.57 | -6.8% | -65.5% | -43.0% | |
| Jan 15, 2025 | Teri Loxam | Director | Sale+OE10b5-1 | 6,250 | $85.11 | $531,962.92 | -46.6% | -66.1% | -46.2% |